Ensysce Biosciences (ENSC) Revenue & Revenue Breakdown
Ensysce Biosciences Revenue Highlights
Latest Revenue (Y)
$2.23M
Ensysce Biosciences Revenue by Period
Ensysce Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $2.23M | -11.61% |
2022-12-31 | $2.52M | -28.54% |
2021-12-31 | $3.53M | -10.18% |
2020-12-31 | $3.93M | 122.86% |
2019-12-31 | $1.76M | 100.00% |
2018-12-31 | - | - |
Ensysce Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | -100.00% |
2024-06-30 | $181.80K | -40.54% |
2024-03-31 | $305.72K | -40.64% |
2023-12-31 | $515.03K | 18.29% |
2023-09-30 | $435.38K | -11.23% |
2023-06-30 | $490.47K | -37.89% |
2023-03-31 | $789.63K | -44.91% |
2022-12-31 | $1.43M | 413.14% |
2022-09-30 | $279.35K | 34.65% |
2022-06-30 | $207.47K | -65.60% |
2022-03-31 | $603.10K | -63.12% |
2021-12-31 | $1.64M | 36.18% |
2021-09-30 | $1.20M | 170.14% |
2021-06-30 | $444.52K | 77.40% |
2021-03-31 | $250.58K | -39.84% |
2020-12-31 | $416.49K | -49.68% |
2020-09-30 | $827.64K | -54.64% |
2020-06-30 | $1.82M | 111.58% |
2020-03-31 | $862.40K | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | - |
Ensysce Biosciences Revenue Breakdown
Ensysce Biosciences Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 |
---|---|---|
M P A R | - | $2.01M |
Latest
Quarterly Revenue by Product
Product/Service | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 |
---|---|---|---|---|---|
MPAR | $437.26K | $481.28K | - | - | - |
M P A R | - | - | $1.30M | - | - |
OUD | - | - | - | $73.06K | $207.47K |
Latest
Ensysce Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ENSC | Ensysce Biosciences | $2.23M | - |
BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
SONN | Sonnet BioTherapeutics | $147.81K | - |
VRAX | Virax Biolabs Group | $8.56K | $76.50K |
PXMD | PaxMedica | - | - |
ZURA | Zura Bio | - | - |
REVB | Revelation Biosciences | - | - |
HILS | Tharimmune | - | - |
ATNF | 180 Life Sciences | - | - |
PHIO | Phio Pharmaceuticals | - | - |
ALLR | Allarity Therapeutics | - | - |
QNRX | Quoin Pharmaceuticals | - | - |
KPRX | Kiora Pharmaceuticals | - | - |
CDIO | Cardio Diagnostics | - | $6.58K |
BWV | Onconetix | - | - |